echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > J Clin Invest: Insulin resistance promotes liver fat production in patients with non-alcoholic fatty liver disease

    J Clin Invest: Insulin resistance promotes liver fat production in patients with non-alcoholic fatty liver disease

    • Last Update: 2020-12-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Increased levels of triglycerides (IHTG) in the liver are a signature feature of non-alcoholic fatty liver disease (NAFLD), which decreases after weight loss.
    new fat production (DNL) in the liver promotes fat degeneration in NAFLD patients.
    , the physiological factors that stimulate liver DNL and the effects of weight loss on liver DNL are not yet known, a study published in J Clin Invest explores.
    study included participants in thinness (n s 14), normal IHTG levels of obesity (n s 26) and non-alcoholic fatty liver (n s 27) to determine liver DNL, 24-hour combined plasma insulin and glucose concentrations, and liver and systemic insulin sensitivity.
    to correct the adipose tissue DNL, the liver DNL was evaluated using radonized water.
    the liver and systemic insulin sensitivity were assessed using the hyperinsepemia-glycemic pliers procedure with glucose tracer infusion.
    the obese-NAFLD group were also assessed before and after a diet-induced 10 percent weight loss.
    results showed that liver DNL contributed 11%, 19% and 38% to IHTG-palmic acid, respectively, in the thin, obese and obesity-NAFLD groups.
    liver DNL was inversely related to liver and systemic insulin sensitivity, but directly related to 24-hour plasma glucose and insulin concentrations.
    weight loss reduced IHTG levels, while liver DNL and 24-hour plasma glucose and insulin concentrations decreased.
    , these data show that liver DNL is an important regulator of IHTG content, and that increased circulating glucose and insulin stimulate liver DNL in patients with non-alcoholic fatty liver disease.
    weight loss can reduce IHTG levels in part by reducing liver DNL.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.